Literature DB >> 26715503

Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature.

Nina Nandy1,2, Joshua A Hanson3, Robert G Strickland4, Denis M McCarthy4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26715503     DOI： 10.1007/s10620-015-4014-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  16 in total

1.  Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion.

Authors:  Jianying Feng; Clark D Petersen; David H Coy; Jian-Kang Jiang; Craig J Thomas; Martin R Pollak; Stephen A Wank
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.

Authors:  Y Haga; T Nakatsura; Y Shibata; H Sameshima; Y Nakamura; M Tanimura; M Ogawa
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 3.  Endocrine tumours of the stomach.

Authors:  Gianfranco Delle Fave; Gabriele Capurso; Massimo Milione; Francesco Panzuto
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

4.  Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge.

Authors:  Edith Lahner; Emanuela Pilozzi; Gianluca Esposito; Gloria Galli; Bruno Annibale
Journal:  Scand J Gastroenterol       Date:  2014-01-13       Impact factor: 2.423

5.  Gastric carcinoid tumors.

Authors:  Russell Wardlaw; James W Smith
Journal:  Ochsner J       Date:  2008

Review 6.  Current status of gastrointestinal carcinoids.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Michael D Shapiro
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

7.  Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.

Authors:  Constantin S Jianu; Ove J Lange; Trond Viset; Gunnar Qvigstad; Tom C Martinsen; Reidun Fougner; Per M Kleveland; Reidar Fossmark; Øyvind Hauso; Helge L Waldum
Journal:  Scand J Gastroenterol       Date:  2011-11-16       Impact factor: 2.423

8.  Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

Authors:  G Rindi; C Bordi; S Rappel; S La Rosa; M Stolte; E Solcia
Journal:  World J Surg       Date:  1996-02       Impact factor: 3.352

Review 9.  Mechanisms of intragastric pH sensing.

Authors:  Tyralee Goo; Yasutada Akiba; Jonathan D Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2010-12

10.  Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis.

Authors:  D Cattan; A M Roucayrol; J M Launay; J Callebert; N Charasz; Y Nurit; J Belaiche; R Kalifat
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682
View more
  12 in total

Review 1.  [Gastric tumors and tumor precursors].

Authors:  C Röcken
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

2.  Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor.

Authors:  Hua Jiang; He Zhang
Journal:  Onco Targets Ther       Date:  2022-05-27       Impact factor: 4.345

3.  Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.

Authors:  Yusuf Karakaş; Şahin Laçin; Olcay Kurtulan; Ece Esin; Veli Sunar; Cenk Sökmensüer; Saadettin Kılıçkap; Şuayib Yalçin
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

4.  Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.

Authors:  Takahiro Suzuki; Takuma Kagami; Takahiro Uotani; Mihoko Yamade; Yasushi Hamaya; Moriya Iwaizumi; Satoshi Osawa; Ken Sugimoto; Hiroaki Miyajima; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2017-10-06       Impact factor: 2.953

Review 5.  Gastrin and Gastric Cancer.

Authors:  Helge L Waldum; Liv Sagatun; Patricia Mjønes
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-17       Impact factor: 5.555

Review 6.  Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer.

Authors:  Márcia Fernanda Correia Jardim Paz; Marcus Vinícius Oliveira Barros de Alencar; Rodrigo Maciel Paulino de Lima; André Luiz Pinho Sobral; Glauto Tuquarre Melo do Nascimento; Cristiane Amaral Dos Reis; Maria do Perpetuo Socorro de Sousa Coêlho; Maria Luísa Lima Barreto do Nascimento; Antonio Luiz Gomes Júnior; Kátia da Conceição Machado; Ag-Anne Pereira Melo de Menezes; Rosália Maria Torres de Lima; José Williams Gomes de Oliveira Filho; Ana Carolina Soares Dias; Antonielly Campinho Dos Reis; Ana Maria Oliveira Ferreira da Mata; Sônia Alves Machado; Carlos Dimas de Carvalho Sousa; Felipe Cavalcanti Carneiro da Silva; Muhammad Torequl Islam; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Oxid Med Cell Longev       Date:  2020-03-28       Impact factor: 6.543

Review 7.  Adverse Effects of Proton Pump Inhibitors-Evidence and Plausibility.

Authors:  Reidar Fossmark; Tom C Martinsen; Helge L Waldum
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

Review 8.  Gastritis, Gastric Polyps and Gastric Cancer.

Authors:  Helge Waldum; Reidar Fossmark
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 9.  Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.

Authors:  Kentaro Sugano
Journal:  Therap Adv Gastroenterol       Date:  2018-01-09       Impact factor: 4.409

Review 10.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.